Shell
SHEL NYSE Integrated Oil & Gas Financials FY2016βFY2025
Shell's revenue fell 6.1% to $266.9 billion in fiscal 2025. Its net margin was 6.7%, up from 5.7% a year earlier. It paid out $22.4 billion in dividends and buybacks. The diluted share count fell 6.5%.
Last close Β· Oct 23, 2026
$108.18
2.2%About these figures. Shell is a foreign company: it files an annual report on Form 20-F, prepared under international accounting standards (IFRS), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model.
What Shell does
No business description yet.
- Legal name
- Shell plc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-017024
0001306965
Revenue and margins
Shell had $266.9B of revenue in fiscal 2025, down 6.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 20.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Shell returned $22.4B to shareholders in fiscal 2025. The diluted share count fell 6.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Shell can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $37.0B | $40.2B | $38.8B | $39.1B | $30.2B |
| Debt incl. finance leases | $89.1B | $83.8B | $81.5B | $77.1B | $75.6B |
| Net debt / EBITDA | 0.9x | 0.5x | 0.6x | 0.6x | 0.8x |
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 9.3x | 21.4x | 8.0x | 7.3x | 7.4x |
| Current ratio | 1.4x | 1.4x | 1.4x | 1.4x | 1.3x |
| Quick ratio | 1.1x | 1.1x | 1.1x | 1.1x | 1.0x |
| Total assets | $404.4B | $443.0B | $406.3B | $387.6B | $370.4B |
| Total liabilities | $229.1B | $250.4B | $217.9B | $207.4B | $195.0B |
| Shareholders' equity | $172.0B | $190.5B | $186.6B | $178.3B | $174.4B |
| Net debt (β = net cash) | $52.1B | $43.5B | $42.8B | $38.0B | $45.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | β8.2% | β9.7% | β6.6% |
| Altman Z'' | 3.48 | 3.41 | 3.36 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Shell SHEL | $643.5B | β6.1% | β | β | 9.6% | β | 5 | |
| ExxonMobil XOM | $764.7B | β5.0% | β | 7.1% | 10.3% | 23.5x | 4 | Compare β |
| TotalEnergies TTE | β | β6.2% | β | β | 10.1% | β | β | Compare β |
| BP BP | β | β1.1% | 6.6% | 5.9% | 6.5% | β | β | Compare β |
| Chevron CVX | $460.6B | β6.8% | β | 8.8% | 6.7% | 22.4x | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $233.6B | $305.2B | $388.4B | $344.9B | $180.5B | $261.5B | $381.3B | $316.6B | $284.3B | $266.9B |
| Research and development | $1.0B | $922M | $986M | $962M | $907M | $815M | $1.1B | $1.3B | $1.1B | $1.2B |
| Interest expense | $3.2B | $4.0B | $3.7B | $4.7B | $4.1B | $3.6B | $3.2B | $4.7B | $4.8B | $4.7B |
| Pretax income | $5.6B | $18.1B | $35.6B | $25.5B | β$27.0B | $29.8B | $64.8B | $32.6B | $29.9B | $29.8B |
| Income tax | $829M | $4.7B | $11.7B | $9.1B | β$5.4B | $9.2B | $21.9B | $13.0B | $13.4B | $11.6B |
| Net income | $4.6B | $13.0B | $23.4B | $15.8B | β$21.7B | $20.1B | $42.3B | $19.4B | $16.1B | $17.8B |
| Diluted EPS | $0.58 | $1.56 | $2.80 | $1.95 | β$2.78 | $2.57 | $5.71 | $2.85 | $2.53 | $3.00 |
| Diluted shares | 7.89B | 8.30B | 8.35B | 8.11B | 7.80B | 7.81B | 7.41B | 6.80B | 6.36B | 5.95B |
| Cash flow | ||||||||||
| Cash from operations | $20.6B | $35.7B | $53.1B | $42.2B | $34.1B | $45.1B | $68.4B | $54.2B | $54.7B | $42.9B |
| Depreciation and amortization | $25.0B | $26.2B | $22.1B | $28.7B | $52.4B | $26.9B | $18.5B | $31.3B | $26.9B | $25.3B |
| Stock-based compensation | $693M | $802M | $531M | $537M | $359M | $539M | $807M | $700M | $732M | $774M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $3.9B | $10.2B | $1.7B | $2.9B | $18.4B | $14.6B | $13.9B | $13.9B |
| Dividends paid | $9.7B | $10.9B | $15.7B | $15.2B | $7.4B | $6.3B | $7.4B | $8.4B | $8.7B | $8.5B |
| Dividends and buybacks | $9.7B | $10.9B | $19.6B | $25.4B | $9.1B | $9.1B | $25.8B | $23.0B | $22.6B | $22.4B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $19.1B | $20.3B | $26.7B | $18.1B | $31.8B | $37.0B | $40.2B | $38.8B | $39.1B | $30.2B |
| Total debt | $92.5B | $85.7B | $76.8B | $96.4B | $108.0B | $89.1B | $83.8B | $81.5B | $77.1B | $75.6B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $86.6B | $95.4B | $97.5B | $92.7B | $92.0B | $128.8B | $165.9B | $134.1B | $127.9B | $107.2B |
| Current liabilities | $73.8B | $79.8B | $77.8B | $79.6B | $73.7B | $95.5B | $121.3B | $95.5B | $95.0B | $82.4B |
| Inventory | $21.8B | $25.2B | $21.1B | $24.1B | $19.5B | $25.3B | $31.9B | $26.0B | $23.4B | $22.2B |
| Property and equipment, net | $236.1B | $226.4B | $223.2B | $238.3B | $209.7B | $194.9B | $198.6B | β | β | β |
| Total assets | $411.3B | $407.1B | $399.2B | $404.3B | $379.3B | $404.4B | $443.0B | $406.3B | $387.6B | $370.4B |
| Total liabilities | $222.8B | $209.3B | $196.7B | $213.9B | $220.7B | $229.1B | $250.4B | $217.9B | $207.4B | $195.0B |
| Shareholders' equity | $186.6B | $194.4B | $198.6B | $186.5B | $155.3B | $172.0B | $190.5B | $186.6B | $178.3B | $174.4B |
| Margins | ||||||||||
| EBITDA margin | 14.5% | 15.9% | 15.8% | 17.1% | 16.4% | 23.1% | 22.7% | 21.7% | 21.7% | 22.4% |
| Net margin | 2.0% | 4.3% | 6.0% | 4.6% | β12.0% | 7.7% | 11.1% | 6.1% | 5.7% | 6.7% |
| Returns | ||||||||||
| Return on capital | β | 6.3% | 10.3% | 7.5% | β7.2% | 10.0% | 19.4% | 9.6% | 8.5% | 9.6% |
| Return on capital employed | β | 6.7% | 12.1% | 9.3% | β7.3% | 10.9% | 21.6% | 11.8% | 11.5% | 11.9% |
| Return on equity | β | 6.8% | 11.9% | 8.2% | β12.7% | 12.3% | 23.4% | 10.3% | 8.8% | 10.1% |
| Return on assets | β | 3.2% | 5.8% | 3.9% | β5.5% | 5.1% | 10.0% | 4.6% | 4.1% | 4.7% |
| Growth | ||||||||||
| Revenue growth | β11.8% | 30.7% | 27.3% | β11.2% | β47.7% | 44.8% | 45.8% | β17.0% | β10.2% | β6.1% |
| Net income growth | 136.0% | 183.7% | 80.0% | β32.2% | β236.9% | β | 110.5% | β54.2% | β16.9% | 10.8% |
| EPS growth | 93.3% | 169.0% | 79.5% | β30.4% | β242.6% | β | 122.2% | β50.1% | β11.2% | 18.6% |
| Share count change | 23.4% | 5.2% | 0.6% | β2.8% | β3.9% | 0.1% | β5.1% | β8.2% | β6.4% | β6.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.2x | 1.4x | 0.8x | 1.3x | 2.6x | 0.9x | 0.5x | 0.6x | 0.6x | 0.8x |
| Debt / equity | 0.5x | 0.4x | 0.4x | 0.5x | 0.7x | 0.5x | 0.4x | 0.4x | 0.4x | 0.4x |
| Interest coverage | 2.8x | 5.5x | 10.5x | 6.4x | β5.6x | 9.3x | 21.4x | 8.0x | 7.3x | 7.4x |
| Current ratio | 1.2x | 1.2x | 1.3x | 1.2x | 1.3x | 1.4x | 1.4x | 1.4x | 1.4x | 1.3x |
| Quick ratio | 0.9x | 0.9x | 1.0x | 0.9x | 1.0x | 1.1x | 1.1x | 1.1x | 1.1x | 1.0x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.3% | 0.3% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | 7.0 | 4.0 | 4.0 | 7.0 | 8.0 | 6.0 | 4.0 | 5.0 |
| Altman Z'' | 2.6 | 3.0 | 3.6 | 3.0 | 1.9 | 3.1 | 3.8 | 3.5 | 3.4 | 3.4 |
| Accruals ratio | β | β5.5% | β7.4% | β6.6% | β14.2% | β6.4% | β6.2% | β8.2% | β9.7% | β6.6% |
Source: SEC EDGAR XBRL filings (CIK 0001306965). Data updated October 23, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.